Clariant AG

SWX:CLN Voorraadrapport

Marktkapitalisatie: CHF 2.7b

Clariant Toekomstige groei

Future criteriumcontroles 3/6

Clariant zal naar verwachting groeien in winst en omzet met respectievelijk 49.4% en 2.1% per jaar. De winst per aandeel zal naar verwachting groeien met 50.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.9% zijn.

Belangrijke informatie

49.4%

Groei van de winst

50.58%

Groei van de winst per aandeel

Chemicals winstgroei8.3%
Inkomstengroei2.1%
Toekomstig rendement op eigen vermogen12.86%
Dekking van analisten

Good

Laatst bijgewerkt23 Apr 2026

Recente toekomstige groei-updates

Recent updates

Analyse-update May 02

CLN: Trimmed Assumptions And Downgrades Will Shape Measured Forward Expectations

Analysts have trimmed their price target on Clariant by CHF 0.09 to reflect updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, in line with recent research that includes a downgrade from some firms. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as more realistic.
Analyse-update Apr 17

CLN: Earnings Quality And Steadier Cash Generation Will Support Bullish Re Rating

Analysts have trimmed their price target on Clariant to CHF 12.37 from CHF 12.77, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E following recent research, including a downgrade from Goldman Sachs. Analyst Commentary While the latest research includes a downgrade from Goldman Sachs, some views across the Street remain constructive, focusing on how Clariant could still convert its fundamentals into long term value creation.
Analyse-update Apr 03

CLN: Recent Downgrade And Trimmed Assumptions Will Shape Potential Upside

Analysts have trimmed their CHF price targets for Clariant by a small amount, reflecting more cautious assumptions on revenue growth and profit margins. They are still applying a slightly higher future P/E multiple in their updated models.
Analyse-update Mar 20

CLN: Lower CHF 7.80 Outlook Will Restrain Upside As Legal Claims Persist

Analysts have trimmed their average price target on Clariant to CHF 7.80 from CHF 8.00, reflecting slightly softer expectations that align with recent downgrades and more cautious assumptions on growth and returns. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the latest moves reflecting concerns around execution, growth visibility and how the current share price lines up with those risks.
Analyse-update Mar 05

CLN: Legal Claims And Recent Downgrade Will Frame Potential Upside Ahead

Analysts have trimmed their price expectations for Clariant, with the average target moving modestly lower to around CHF 7.80. This reflects updated assumptions on fair value, discount rates and future P/E in light of recent research calls.
Analyse-update Feb 19

CLN: Legal Claims And Rating Downgrade Will Shape Measured Future Upside Potential

The updated analyst price target for Clariant now stands at CHF 8.80, a small change from the prior CHF 8.74, as analysts factor in recent target cuts around CHF 7.80 and adjust their assumptions on discount rates, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts see the updated CHF 8.80 target as reflecting a more refined view of discount rates and earnings power, rather than a fundamental shift in the story.
Analyse-update Feb 05

CLN: Lower CHF 7.80 Outlook Will Cap Upside As Legal Claims Linger

Analysts have reduced their price target on Clariant to CHF 7.80 from CHF 8.00 to reflect updated views on the company’s discount rate, revenue growth assumptions, profit margins and future P/E. Analyst Commentary Bearish analysts are signaling a more cautious stance on Clariant by aligning their valuation work with a CHF 7.80 price level.
Analyse-update Jan 22

CLN: Revised Expectations And Legal Claims Will Shape Future Upside Potential

Analysts have reduced their price target for Clariant to CHF 7.80 from CHF 8.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the price target trimmed to CHF 7.80 from CHF 8 and the rating held steady at Hold.
Analyse-update Jan 07

CLN: Legal Claims And Steady Earnings Outlook Will Support Bullish Re Rating

Analysts have trimmed their price target on Clariant to CHF 7.80, reflecting updated assumptions for fair value, revenue growth, margins and future P/E multiples following recent research. Analyst Commentary Recent research points to a more measured stance on Clariant, with the revised CHF 7.80 target reflecting updated views on valuation, earnings power and the multiples investors might be willing to pay for the shares.
Analyse-update Dec 21

CLN: Reduced Price Outlook Will Limit Upside Amid Rising Legal Risks

Analysts have reduced their price target on Clariant by CHF 1.50 to CHF 8.10, reflecting more cautious assumptions on revenue growth and valuation multiples, even though margin expectations have improved slightly. Analyst Commentary Bearish analysts have framed the lower price target as a reflection of rising skepticism around Clariant's ability to deliver on its medium term growth ambitions, despite recent progress on margins.
Analyse-update Dec 07

CLN: Margin Recovery And Legal Overhang Will Shape Future Share Resilience

Analysts have trimmed their price target on Clariant by CHF 1.50 to reflect a slightly lower assumed future price to earnings multiple and discount rate, even as forecasts for profit margins have improved. Analyst Commentary Analysts remain balanced in their view on Clariant, with modest adjustments to valuation assumptions reflecting both improving profitability and lingering execution risks.
Analyse-update Nov 23

CLN: Market Recovery And Margin Discipline Will Drive Future Share Resilience

Clariant's analyst price target has been revised downward from CHF 9.78 to CHF 9.51. Analysts cite tempered expectations for near-term performance amid evolving market conditions.
Analyse-update Nov 07

CLN: Margin Improvements And Efficiency Efforts Will Offset Market Headwinds

Analysts have reduced their price target for Clariant from CHF 9.60 to CHF 8.10. This adjustment reflects lowered growth expectations and a more cautious outlook on the company's future performance.
Analyse-artikel Nov 04

Cautious Investors Not Rewarding Clariant AG's (VTX:CLN) Performance Completely

There wouldn't be many who think Clariant AG's ( VTX:CLN ) price-to-earnings (or "P/E") ratio of 20.4x is worth a...
Analyse-update Oct 24

Earnings Recovery Will Depend On Stabilization And Cost Improvements Amid Headwinds

Narrative Update: Clariant Analyst Price Target Adjustment Clariant’s analyst price target has been reduced significantly, dropping from CHF 9.60 to CHF 8.10. Analysts cite softer revenue growth and profit margin expectations in their revised outlook.
Analyse-update Oct 10

China Expansion And Sustainable Solutions Will Boost Long-Term Appeal

Narrative Update on Clariant Clariant's analyst price target has been revised downward from CHF 10.95 to CHF 10.58. Analysts cite a combination of cautious revenue growth assumptions and a recent reduction in price targets by major banks.
Analyse-update Sep 26

China Expansion And Sustainable Solutions Will Boost Long-Term Appeal

The minor decrease in Clariant's price target reflects a combination of lower revenue growth expectations and a modestly higher discount rate, resulting in a slight fair value reduction to CHF10.95. What's in the News Clariant AG dropped from the FTSE All-World Index (USD).
Analyse-artikel Sep 17

Is Clariant AG (VTX:CLN) Trading At A 32% Discount?

Key Insights Clariant's estimated fair value is CHF11.89 based on 2 Stage Free Cash Flow to Equity Current share price...
Analyse-artikel Aug 26

We Think Clariant (VTX:CLN) Is Taking Some Risk With Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyse-artikel Aug 08

Clariant's (VTX:CLN) Anemic Earnings Might Be Worse Than You Think

SWX:CLN 1 Year Share Price vs Fair Value Explore Clariant's Fair Values from the Community and select yours Clariant...
Analyse-artikel May 30

Clariant (VTX:CLN) Has Affirmed Its Dividend Of CHF0.42

Clariant AG ( VTX:CLN ) has announced that it will pay a dividend of CHF0.42 per share on the 4th of June. Based on...
Analyse-artikel May 05

These 4 Measures Indicate That Clariant (VTX:CLN) Is Using Debt Extensively

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyse-artikel Apr 13

Are Investors Undervaluing Clariant AG (VTX:CLN) By 39%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Clariant fair value estimate is CHF13.37 Current share price...
Analyse-artikel Mar 26

Clariant AG's (VTX:CLN) CEO Might Not Expect Shareholders To Be So Generous This Year

Key Insights Clariant's Annual General Meeting to take place on 1st of April Salary of CHF1.20m is part of CEO Conrad...
Analyse-artikel Mar 05

Clariant AG Just Missed EPS By 6.0%: Here's What Analysts Think Will Happen Next

It's been a sad week for Clariant AG ( VTX:CLN ), who've watched their investment drop 10% to CHF9.76 in the week since...
Analyse-artikel Mar 02

Take Care Before Diving Into The Deep End On Clariant AG (VTX:CLN)

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") above 21x, you may consider...
User avatar
Nieuwe analyse Dec 18

Restructuring, Lucas Meyer Cosmetics, And Sunliquid Set To Boost Margins And Drive Earnings

Identifying restructuring opportunities and targeting significant savings could improve Clariant's net margins and earnings efficiency in the coming years.
Analyse-artikel Nov 27

Estimating The Intrinsic Value Of Clariant AG (VTX:CLN)

Key Insights The projected fair value for Clariant is CHF10.85 based on 2 Stage Free Cash Flow to Equity Clariant's...
Analyse-artikel Nov 09

It's A Story Of Risk Vs Reward With Clariant AG (VTX:CLN)

Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now...
Analyse-artikel Aug 07

Clariant's (VTX:CLN) Solid Earnings Have Been Accounted For Conservatively

The stock was sluggish on the back of Clariant AG's ( VTX:CLN ) recent earnings report. Our analysis suggests that...
Analyse-artikel Jul 17

Why Investors Shouldn't Be Surprised By Clariant AG's (VTX:CLN) Low P/S

Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 1.1x might make it look like a strong buy right now...
Analyse-artikel Apr 23

What Is Clariant AG's (VTX:CLN) Share Price Doing?

Clariant AG ( VTX:CLN ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Analyse-artikel Apr 03

Increases to Clariant AG's (VTX:CLN) CEO Compensation Might Cool off for now

Key Insights Clariant to hold its Annual General Meeting on 9th of April Total pay for CEO Conrad Keijzer includes...
Analyse-artikel Nov 22

An Intrinsic Calculation For Clariant AG (VTX:CLN) Suggests It's 50% Undervalued

Key Insights The projected fair value for Clariant is CHF25.95 based on 2 Stage Free Cash Flow to Equity Current share...
Analyse-artikel Oct 31

Clariant (VTX:CLN) Takes On Some Risk With Its Use Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analyse-artikel Jul 30

Clariant (VTX:CLN) Seems To Use Debt Quite Sensibly

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Winst- en omzetgroeiprognoses

SWX:CLN - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CHF Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20284,0762603735939
12/31/20273,98326135657915
12/31/20263,84421532257414
12/31/20253,915-75273419N/A
9/30/20253,98919250421N/A
6/30/20254,063113226422N/A
3/31/20254,108179218420N/A
12/31/20244,152244210418N/A
6/30/20244,163118251455N/A
3/31/20244,270143233438N/A
12/31/20234,377168215421N/A
6/30/20234,919-98400597N/A
3/31/20235,059-115346550N/A
12/31/20225,198-133291502N/A
9/30/20225,050107153417N/A
6/30/20224,90134615331N/A
3/31/20224,6373059347N/A
12/31/20214,3722633363N/A
9/30/20214,161199-16329N/A
6/30/20213,949135-35295N/A
3/31/20213,90512118332N/A
12/31/20203,86010671369N/A
6/30/20204,115141192485N/A
3/31/20204,25740207497N/A
12/31/20194,399-62221509N/A
6/30/20194,409-67N/A541N/A
3/31/20194,40764N/A536N/A
12/31/20184,404194N/A530N/A
9/30/20184,937223N/AN/AN/A
6/30/20185,469251N/A414N/A
3/31/20185,923264N/A421N/A
12/31/20176,377277N/A428N/A
9/30/20176,229276N/A491N/A
6/30/20176,080274N/A554N/A
3/31/20175,964264N/A600N/A
12/31/20165,847253N/A646N/A
9/30/20165,899211N/A733N/A
6/30/20165,835203N/A645N/A
3/31/20165,792195N/A592N/A
12/31/20155,807217N/A502N/A
9/30/20155,867275N/A517N/A
6/30/20155,964272N/A512N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er wordt voorspeld dat CLN de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 0.6% ).

Winst versus markt: Er wordt verwacht dat CLN de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.

Hoge groeiwinsten: Er wordt verwacht dat CLN binnen 3 jaar winstgevend zal worden.

Omzet versus markt: De omzet van CLN ( 2.1% per jaar) zal naar verwachting langzamer groeien dan de markt Swiss ( 4.9% per jaar).

Hoge groei-inkomsten: De omzet van CLN ( 2.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen CLN zal naar verwachting over 3 jaar laag zijn ( 12.9 %).


Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/08 23:30
Aandelenkoers aan het einde van de dag2026/05/08 00:00
Inkomsten2025/12/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Clariant AG wordt gevolgd door 35 analisten. 15 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
Katie RichardsBarclays